The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Open accessAbstract
Conventional cancer therapies suffer from severe off-target effects because most of them target critical facets of cells that are generally shared by all rapidly proliferating cells. The development of new therapeutic agents should aim to increase selectivity and therefore reduce side effects. In addition, these agents should overcome cancer cell resistance and target cancer stem cells. Some copper ionophores have shown promise in this direction thanks to an intrinsic selectivity in preferentially inducing cuproptosis of cancer cells compared to normal cells. Here, Cu ionophores are discussed with a focus on selectivity towards cancer cells and on the mechanisms responsible for this selectivity. The proposed strategies, to further improve the targeting of cancer cells by copper ionophores, are also reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452 · cited 1×
“Cancer cells are characterized by an altered ROS production, compared to normal cells (Trachootham et al., 2009).”
BackgroundChemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201805664 · Cited by 1,951
Connecting copper and cancer: from transition metal signalling to metalloplasia
Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S., et al. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,298
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807 · cited 1×
“Mounting evidence has demonstrated that CuDSF can have several targets including ROS levels, the ubiquitinproteasome system (UPS), nuclear factor-kappa B (NF-κB), NPL4 (Chen et al., 2006; Skrott et al., 2017; Oliveri, 2020; Kannappan et al., 2021).”
BackgroundTargeting copper in cancer therapy: ‘Copper That Cancer’
Denoyer, D., Masaldan, S., La Fontaine, S., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 806
Recent progress of chemodynamic therapy-induced combination cancer therapy
Wang, X., Zhong, X., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100946 · Cited by 711
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Mitochondrial metabolism promotes adaptation to proteotoxic stress
Tsvetkov, P., Detappe, A., Cai, K., Keys, H. R., Brune, Z., Ying, W., Thiru, P., Reidy, M., Kugener, G., Rossen, J., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0291-9 · Cited by 645
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
D'Souza, A. A., & Devarajan, P. V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.022 · Cited by 621
Role of Copper on Mitochondrial Function and Metabolism
Ruiz, L. M., Libedinsky, A., & Elorza, A. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.711227 · Cited by 564
Nogueira, V., & Hay, N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1424 · Cited by 514
Expression of glucose transporters in cancers
Szablewski, L. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.004 · Cited by 452
PC3 is a cell line characteristic of prostatic small cell carcinoma
Tai, S., Sun, Y., Squires, J. M., Zhang, H., Oh, W. K., Liang, C., & Huang, J. (2011) · The Prostate · doi:10.1002/pros.21383 · Cited by 438
Bioavailable copper modulates oxidative phosphorylation and growth of tumors
Ishida, S., Andreux, P., Poitry-Yamate, C., Auwerx, J., & Hanahan, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318431110 · Cited by 422
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Copper metabolism as a unique vulnerability in cancer
Shanbhag, V. C., Gudekar, N., Jasmer, K., Papageorgiou, C., Singh, K., & Petris, M. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118893 · Cited by 368
Wu, W., Yu, L., Jiang, Q., Huo, M., Lin, H., Wang, L., Chen, Y., & Shi, J. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03503 · Cited by 359
Nagai, M., Vo, N. H., Shin Ogawa, L., Chimmanamada, D., Inoue, T., Chu, J., Beaudette-Zlatanova, B. C., Lu, R., Blackman, R. K., Barsoum, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.017 · Cited by 357
Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1322 · Cited by 326
ROS-modulated therapeutic approaches in cancer treatment
Raza, M. H., Siraj, S., Arshad, A., Waheed, U., Aldakheel, F., Alduraywish, S., & Arshad, M. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2464-9 · Cited by 297
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Walther, R., Rautio, J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.013 · Cited by 288
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Aubert, L., Nandagopal, N., Steinhart, Z., Lavoie, G., Nourreddine, S., Berman, J., Saba-El-Leil, M. K., Papadopoli, D., Lin, S., Hart, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17549-y · Cited by 287
Copper homeostasis: Emerging target for cancer treatment
Li, Y. (2020) · IUBMB Life · doi:10.1002/iub.2341 · Cited by 282
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-420117-0.00003-7 · Cited by 271
Lelièvre, P., Sancey, L., Coll, J.-L., Deniaud, A., & Busser, B. (2020) · Cancers · doi:10.3390/cancers12123594 · Cited by 271
Allensworth, J. L., Evans, M. K., Bertucci, F., Aldrich, A. J., Festa, R. A., Finetti, P., Ueno, N. T., Safi, R., McDonnell, D. P., Thiele, D. J., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.007 · Cited by 240
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
Tang, Z., Liu, Y., He, M., & Bu, W. (2019) · Angewandte Chemie · doi:10.1002/ange.201805664 · Cited by 240
Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients
Saleh, S. A. K., Adly, H. M., Abdelkhaliq, A. A., & Nassir, A. M. (2020) · Current Urology · doi:10.1159/000499261 · Cited by 239
Steinbrueck, A., Sedgwick, A. C., Brewster, J. T., Yan, K.-C., Shang, Y., Knoll, D. M., Vargas-Zúñiga, G. I., He, X.-P., Tian, H., & Sessler, J. L. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00373h · Cited by 214
O'Day, S., Gonzalez, R., Lawson, D., Weber, R., Hutchins, L., Anderson, C., Haddad, J., Kong, S., Williams, A., & Jacobson, E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1579 · Cited by 208
Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
Safi, R., Nelson, E. R., Chitneni, S. K., Franz, K. J., George, D. J., Zalutsky, M. R., & McDonnell, D. P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3527 · Cited by 201
Redox Dyshomeostasis Strategy for Hypoxic Tumor Therapy Based on DNAzyme‐Loaded Electrophilic ZIFs
Li, Y., Zhao, P., Gong, T., Wang, H., Jiang, X., Cheng, H., Liu, Y., Wu, Y., & Bu, W. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003653 · Cited by 197
Li, Y., Chen, F., Chen, J., Chan, S., He, Y., Liu, W., & Zhang, G. (2020) · Cancers · doi:10.3390/cancers12010138 · Cited by 188
The combination of disulfiram and copper for cancer treatment
Li, H., Wang, J., Wu, C., Wang, L., Chen, Z.-S., & Cui, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.003 · Cited by 185
Babak, M. V., & Ahn, D. (2021) · Biomedicines · doi:10.3390/biomedicines9080852 · Cited by 179
Baltacı, A. K., DÜNDAR, T. K., Aksoy, F., & Moğulkoç, R. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0768-2 · Cited by 170
Biomedical applications of copper ionophores
Oliveri, V. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213474 · Cited by 169
Self-citationAssociation between serum copper levels and lung cancer risk: A meta-analysis
Zhang, X., & Yang, Q. (2018) · Journal of International Medical Research · doi:10.1177/0300060518798507 · Cited by 168
Hothi, P., Martins, T. J., Chen, L., Deleyrolle, L. P., Yoon, J., Reynolds, B. A., & Foltz, G. (2012) · Oncotarget · doi:10.18632/oncotarget.707 · Cited by 166
Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
Cater, M. A., Pearson, H. B., Wolyniec, K., Klaver, P., Bilandzic, M., Paterson, B. M., Bush, A. I., Humbert, P. O., La Fontaine, S., Donnelly, P. S., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400198p · Cited by 165
Serum Levels of Metal Ions in Female Patients with Breast Cancer
Pavithra, V., Sathisha, T. G., Kasturi, K. S., Mallika, D. S., Amos, S. J., & Ragunatha, S. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11627.5476 · Cited by 161
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
Chen, W., Yang, W. L., Chen, P., Huang, Y., & Li, F. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14940 · Cited by 159
Stępień, M., Jenab, M., Freisling, H., Becker, N., Czuban, M., Tjønneland, A. M., Olsen, A., Overvad, K., Boutron‐Ruault, M., Mancini, F. R., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx051 · Cited by 155
Xu, B., Wang, S., Li, R., Chen, K., He, L., Deng, M., Kannappan, V., Zha, J., Dong, H., & Wang, W. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.176 · Cited by 152
Kannappan, V., Ali, M., Small, B., Rajendran, G., Elzhenni, S., Taj, H., Wang, W., & Dou, Q. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.741316 · Cited by 151
Jiang, H., Taggart, J. E., Zhang, X., Benbrook, D. M., Lind, S. E., & Ding, W. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.032 · Cited by 147
Patra, M., Awuah, S. G., & Lippard, S. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06937 · Cited by 145
Serum and tissue trace elements in colorectal cancer
Gupta, S., Shukla, V. K., Vaidya, M. P., Roy, S. K., & Gupta, S. (1993) · Journal of Surgical Oncology · doi:10.1002/jso.2930520311 · Cited by 129
Mao, X., & Schimmer, A. D. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.08.015 · Cited by 129
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Ekinci, E., Rohondia, S. O., Khan, R., & Dou, Q. P. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190514104035 · Cited by 129
Donnelly, P. S., Liddell, J. R., Lim, S., Paterson, B. M., Cater, M. A., Savva, M. S., Mot, A. I., James, J. L., Trounce, I. A., White, A. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116227108 · Cited by 123
Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit
Hunsaker, E. W., & Franz, K. J. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01029 · Cited by 118
Monk, B. J., Kauderer, J. T., Moxley, K. M., Bonebrake, A. J., Dewdney, S. B., Secord, A. A., Ueland, F. R., Johnston, C. M., & Aghajanian, C. A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.001 · Cited by 115
Clioquinol targets zinc to lysosomes in human cancer cells
Yu, H., Zhou, Y., Lind, S. E., & Ding, W. (2008) · Biochemical Journal · doi:10.1042/bj20081421 · Cited by 114
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
Moradi, A., Srinivasan, S., Clements, J., & Batra, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09815-3 · Cited by 114
Liu, X., Wang, L., Cui, W., Yuan, X., Lin, L., Cao, Q., Wang, N., Li, Y., Guo, W., Zhang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11305 · Cited by 112
Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China
Ding, X., Jiang, M., Jing, H., Sheng, W., Wang, X., Han, J., & Wang, L. (2014) · Environmental Science and Pollution Research · doi:10.1007/s11356-014-3970-9 · Cited by 110
Wang, D., Huang, J., Wang, X., Yu, Y., Zhang, H., Chen, Y., Liu, J., Sun, Z., Zou, H. L., Sun, D., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.042 · Cited by 110
Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy
McMahon, A., Chen, W., & Li, F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.001 · Cited by 105
Denoyer, D., Pearson, H. B., Clatworthy, S. A. S., Smith, Z. M., Francis, P. S., Llanos, R. M., Volitakis, I., Phillips, W. A., Meggyesy, P. M., Masaldan, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9245 · Cited by 100
Michniewicz, F., Saletta, F., Rouaen, J. R. C., Hewavisenti, R., Mercatelli, D., Cirillo, G., Giorgi, F. M., Trahair, T. N., Ziegler, D. S., & Vittorio, O. (2021) · ChemMedChem · doi:10.1002/cmdc.202100172 · Cited by 91
Pan, Q., Zhang, B., Peng, X., Wan, S., Luo, K., Gao, W., Pu, Y., & He, B. (2019) · Chemical Communications · doi:10.1039/c9cc05438c · Cited by 90
Hassani, S., Ghaffari, P., Chahardouli, B., Alimoghaddam, K., Ghavamzadeh, A., Alizadeh, S., & Ghaffari, S. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.109 · Cited by 88
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment
Maslah, H., Skarbek, C., Pèthe, S., & Labruère, R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112670 · Cited by 87
Chen, F., Wang, J., Chen, J., Yan, L., Hu, Z., Wu, J., Bao, X., Lin, L., Wang, R., Cai, L., et al. (2018) · Oral Diseases · doi:10.1111/odi.12957 · Cited by 84
Hasinoff, B. B., Yadav, A. A., Patel, D., & Wu, X. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.004 · Cited by 81
Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment
Fu, J., Yang, J., Seeberger, P. H., & Yin, J. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108195 · Cited by 79
Wangpaichitr, M., Wu, C., You, M., Maher, J. C., Dinh, V., Feun, L. G., & Savaraj, N. (2009) · Cancers · doi:10.3390/cancers1010023 · Cited by 75
Cater, M. A., & Haupt, Y. (2011) · Biochemical Journal · doi:10.1042/bj20110123 · Cited by 74
Bakthavatsalam, S., Sleeper, M. L., Dharani, A. M., George, D. J., Zhang, T., & Franz, K. J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807582 · Cited by 74
Sun, T., Yang, W., Toprani, S. M., Guo, W., He, L., DeLeo, A. B., Ferrone, S., Zhang, G., Wang, E., Lin, Z., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0507-3 · Cited by 74
Cao, B., Li, J., Zhou, X., Juan, J., Han, K., Zhang, Z., Kong, Y., Wang, J., & Mao, X. (2014) · Scientific Reports · doi:10.1038/srep05749 · Cited by 70
He, H., Markoutsa, E., Li, J., & Xu, P. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.023 · Cited by 70
A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals
Su, T. A., Shihadih, D. S., Cao, W., Detomasi, T. C., Heffern, M. C., Jia, S., Stahl, A., & Chang, C. J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08014 · Cited by 68
Chang, Y., Jiang, J., Wu, C., Yang, W. L., Chen, L., Chen, P., Shen, J., Qian, S., Zhou, T., Wu, L., et al. (2019) · Applied Materials Today · doi:10.1016/j.apmt.2019.100492 · Cited by 65
Ji, Y., Dai, F., & Zhou, B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.017 · Cited by 64
Zhang, J., Duan, D., Xu, J., & Fang, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11061 · Cited by 55
Hickey, J. L., Crouch, P. J., Mey, S., Caragounis, A., White, J. M., White, A. R., & Donnelly, P. S. (2010) · Dalton Transactions · doi:10.1039/c0dt01176b · Cited by 52
Vella, V., Malaguarnera, R., Lappano, R., Maggiolini, M., & Belfiore, A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.020 · Cited by 50
Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
Park, Y. M., Go, Y. Y., Shin, S. H., Cho, J., Woo, J., & Song, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203069 · Cited by 49
Copper as the Target for Anticancer Nanomedicine
Shao, S., Si, J., & Shen, Y. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800147 · Cited by 49
Ma, J., Wang, Q., Yang, X., Hao, W., Huang, Z., Zhang, J., Wang, X., & Wang, P. G. (2016) · Dalton Transactions · doi:10.1039/c6dt02207c · Cited by 48
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201510551 · Cited by 43
Development of a copper-clioquinol formulation suitable for intravenous use
Wehbe, M., Malhotra, A. K., Anantha, M., Lo, C., Dragowska, W. H., Santos, N. D., & Bally, M. B. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0455-7 · Cited by 43
Prochelator strategies for site-selective activation of metal chelators
Oliveri, V., & Vecchio, G. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.05.012 · Cited by 42
Self-citationFalls-Hubert, K. C., Butler, A. L., Gui, K., Anderson, M., Li, M., Stolwijk, J. M., Rodman, S. N., Solst, S. R., Tomanek‐Chalkley, A., Searby, C. C., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.186 · Cited by 42
Bao, X., Wang, Q., Ren, X., Dai, F., & Zhou, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.001 · Cited by 36
Kang, X., Cai, Y., Wang, Q., Wang, C., Chen, W., Yang, W. L., Suryawanshi, A. S., Zhou, G., Chen, P., & Li, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120972 · Cited by 34
Bao, X., Dai, F., Li, X., & Zhou, B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.021 · Cited by 33
Summers, K. L., Dolgova, N. V., Gagnon, K. B., Sopasis, G. J., James, A. K., Lai, B. C. H., Sylvain, N. J., Harris, H. H., Nichol, H. K., George, G. N., et al. (2020) · Metallomics · doi:10.1039/d0mt00222d · Cited by 23
Serra, R., Zhao, T., Huq, S., Gorelick, N. L., Casaos, J., Cecia, A. F., Mangraviti, A., Eberhart, C. G., Bai, R.-Y., Olivi, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251957 · Cited by 19
Dai, F., Yuan, C., Ji, Y., Du, Y., Bao, X., Wu, L., Jin, X., & Zhou, B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.029 · Cited by 18
Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer
Bakthavatsalam, S., Wiangnak, P., George, D. J., Zhang, T., & Franz, K. J. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127148 · Cited by 17
P(MMA‐co‐AA) Nanoparticles Loaded with Clioquinol and Functionalized with TAT Peptide
Campos, I. M. F., de Barros, I. R., Ferraz, H. C., & Pinto, J. C. (2019) · Macromolecular Reaction Engineering · doi:10.1002/mren.201900046 · Cited by 9
Bakthavatsalam, S., Sleeper, M. L., Dharani, A. M., George, D. J., Zhang, T., & Franz, K. J. (2018) · Angewandte Chemie · doi:10.1002/ange.201807582 · Cited by 8
Cited by
Cuproptosis: mechanisms and links with cancers
Xie, J., Yang, Y., Gao, Y., & He, J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01732-y · Cited by 801
Chen, X., Cai, Q., Liang, R., Zhang, D., Liu, X., Zhang, M., Xiong, Y., Xu, M., Liu, Q., Li, P., et al. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05639-w · Cited by 278
Zhang, Z., Zeng, X., Wu, Y., Liu, Y., Zhang, X., & Song, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925618 · Cited by 275
Xu, W., Qian, J., Hou, G., Wang, T., Wang, J., Wang, Y., Yang, L., Cui, X., & Suo, A. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205013 · Cited by 267
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Metadata
- Authors
- Oliveri, V.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2022-03-04
- Volume
- 9
- Pages
- 841814-841814
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W4214862149
- Cited by
- 367
- References
- 97
- FWCI
- 42.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.